sigma-tau
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. was an Italian pharmaceutical group founded in 1957 that manufactured and marketed medicinal specialties. The company ceased independent operations on August 1, 2017, when it merged by incorporation into Alfasigma S.p.A.
- Company typePrivate
- Founded1957
- HeadquartersVico Nel Lazio, Italy
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What sigma-tau does
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. was an Italian pharmaceutical group that manufactured and marketed medicinal specialties. Founded in 1957 by Claudio Cavazza, the company operated as a vertically integrated pharmaceutical business organized under Italian law as a società per azioni (S.p.A.), with a workforce of 5,001–10,000 employees. Its core function was the production and distribution of pharmaceutical products under Italian Marketing Authorizations (Autorizzazione all'Immissione in Commercio, AIC), serving the Italian and broader European pharmaceutical market. The company held proprietary marketing authorizations across a portfolio of medicinal specialties accumulated over approximately six decades of operation.
Following decades of independent operation, Sigma-Tau ceased to exist as a separate legal entity on August 1, 2017, through a three-way merger by incorporation into Alfasigma S.p.A., alongside Alfa Wassermann S.p.A. and Biofutura Pharma S.p.A. Alfasigma, headquartered at Via Ragazzi del '99, 5 – 40133 Bologna, Italy (P.IVA 03432221202), assumed all assets, liabilities, and marketing authorizations of the merged entities. The legacy sigma-tau.it domain was retained only to complete the regulatory transfer of AIC holders and was redirected to the Alfasigma corporate site. The legal and administrative headquarters formerly associated with Sigma-Tau in Bologna were transferred to Alfasigma upon completion of the merger.
The company generated revenue through pharmaceutical manufacturing and distribution of its proprietary medicinal specialty portfolio, though no product names, pricing models, distribution channel details, or revenue figures are disclosed in the available source data. All revenue-generating operations and product portfolios are now consolidated under Alfasigma S.p.A., making Sigma-Tau's independent operating history effectively concluded.
sigma-tau firmographics
Firmographics- Name
- sigma-tau
- Legal name
- Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- Website
- https://sigma-tau.it
- Company type
- Private
- Founded year
- 1957
- Operating status
- Acquired
- Headcount range
- 5,001–10,000 employees
- Short description
- Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. was an Italian pharmaceutical group founded in 1957 that manufactured and marketed medicinal specialties. The company ceased independent operations on August 1, 2017, when it merged by incorporation into Alfasigma S.p.A.
- Ownership category
- akta.pro rank
Where sigma-tau is headquartered
LocationHeadquarters
- HQ city
- Vico Nel Lazio
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
sigma-tau business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
sigma-tau product offering
Product offeringCore offering
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. was an Italian pharmaceutical company that manufactured and marketed medicinal specialties (specialità medicinali) and pharmaceutical products under registered Marketing Authorizations (AIC). All products, assets, and Marketing Authorizations were transferred to Alfasigma S.p.A. upon the merger effective August 1, 2017.
Product overview
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. was an Italian pharmaceutical company. As of August 1, 2017, it merged by absorption into Alfasigma S.p.A. along with Alfa Wassermann S.p.A. and Biofutura Pharma S.p.A. The company was involved in the production and distribution of medicinal specialties (specialità medicinali). This legacy page is maintained only to complete the transfer of marketing authorization holders (AIC) to Alfasigma. No specific product names are detailed in the available source data.
Differentiator
Problem solved
Functional benefit
Companies that use sigma-tau
Customer profileSegments1 record
Ideal customer profiles1 record
sigma-tau technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
sigma-tau partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights1 record
sigma-tau competitors and assessment
Company assessmentDirect peers
- Alfasigma S.p.A. Alfasigma is the Italian specialty-pharma group that absorbed Sigma-Tau by merger on 1 August 2017 along with Alfa Wassermann and Biofutura Pharma. It is now the direct continuation of Sigma-Tau's medicinal specialty business and is headquartered in Bologna.
- Menarini Group: Florence-based privately held Italian pharmaceutical group of comparable mid-large size focused on branded specialty therapeutics, prescription drugs and consumer health - structurally analogous to Sigma-Tau's Italian pharma house positioning.
- Chiesi Farmaceutici S.p.A. Privately held Italian specialty pharma headquartered in Parma with comparable scale, manufacturing medicinal products for respiratory, neonatology and rare disease - a closely comparable Italian branded-pharma peer to Sigma-Tau.
- Recordati S.p.A. Listed Italian mid-cap specialty pharmaceutical company headquartered in Milan, focused on branded prescription drugs in cardiovascular, urology and rare diseases - directly comparable in scale, geography and product mix to Sigma-Tau's medicinal specialty business.
- Zambon S.p.A. Italian privately held pharmaceutical group (Bresso/Milan) producing and marketing branded medicinal specialties across respiratory, pain and CNS - comparable mid-sized Italian specialty pharma peer to Sigma-Tau.
- Angelini Pharma: Angelini group's pharma division, an Italian privately held branded-pharma manufacturer of medicinal specialties (CNS, pain, infectious disease) - similar scope, scale and Italian distribution model to Sigma-Tau.
- Dompé Farmaceutici S.p.A. Italian privately held biopharma company headquartered in Milan with both specialty pharmaceuticals and biotech products - comparable mid-sized Italian pharma peer serving similar hospital and prescription channels.
- Italfarmaco S.p.A. Italian privately held pharmaceutical group (Milan) developing, manufacturing and marketing medicinal specialties in women's health, rare disease and specialty therapeutics - similar branded-pharma positioning and scale to Sigma-Tau.
- Molteni Farmaceutici: Italian privately held specialty pharmaceutical company focused on pain management and medicinal specialties - directly comparable on business model and Italian specialty-pharma positioning to Sigma-Tau, though smaller in scale.
- Alfa Wassermann S.p.A. The Italian pharma company that merged with Sigma-Tau and Biofutura Pharma into Alfasigma on 1 August 2017; a historical direct peer of Sigma-Tau in Italian pharmaceutical manufacturing and distribution.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
sigma-tau social profiles
Digital presencesigma-tau financial estimates
Financial estimateRevenue estimate
Valuation estimate
sigma-tau leadership team
Management profileNumber of profiles
sigma-tau funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
sigma-tau M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about sigma-tau
What does sigma-tau do?
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. was an Italian pharmaceutical company that manufactured and marketed medicinal specialties (specialità medicinali) and pharmaceutical products under registered Marketing Authorizations (AIC). All products, assets, and Marketing Authorizations were transferred to Alfasigma S.p.A. upon the merger effective August 1, 2017.
Is sigma-tau a public or private company?
sigma-tau is a private company. It is classified as corporate owned and is currently acquired.
When was sigma-tau founded?
sigma-tau was founded in 1957. It employs 5,001 to 10,000 people.
Where is sigma-tau based?
sigma-tau is headquartered in Vico Nel Lazio, Italy, in the Europe region.
Who are sigma-tau's main competitors?
Direct peers on record are Alfasigma S.p.A., Menarini Group, Chiesi Farmaceutici S.p.A., Recordati S.p.A., Zambon S.p.A., Angelini Pharma, Dompé Farmaceutici S.p.A., Italfarmaco S.p.A., Molteni Farmaceutici and Alfa Wassermann S.p.A..
Does sigma-tau have an API?
No public API is recorded for sigma-tau.